drugset / Trial / NCT03944031
A Study of the Effects of LY3372689 on the Brain in Healthy Participants
NaSingle-groupOpen-labelBasic science
Summary
This study uses imaging to evaluate how LY3372689 binds to a protein in the brain. This study will be conducted in healthy participants and will last up to approximately 25 days after enrollment. Screening must be completed within 28 days prior to enrollment.
Timeline
- Start
- 2019-05-08
- Primary completion
- 2020-02-19
- Completion
- 2020-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ceperognastat | Small molecule | — | Oral |
Indications
No indication recorded.